{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:35:34Z","timestamp":1762673734757},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T00:00:00Z","timestamp":1251331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T00:00:00Z","timestamp":1251331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10637-009-9300-2","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T02:24:46Z","timestamp":1251253486000},"page":"609-614","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["In vitro cytotoxic evaluation of novel dichlorodiorgano[N-(2-pyridylmethylene)arylamine]tin(IV) derivatives in human tumor cell lines"],"prefix":"10.1007","volume":"28","author":[{"given":"Tushar S.","family":"Basu Baul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"de Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,27]]},"reference":[{"key":"9300_CR1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2174\/092986706776872970","volume":"13","author":"AS Abu-Surrah","year":"2006","unstructured":"Abu-Surrah AS, Kettunen M (2006) Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. Curr Med Chem 13:1337\u20131357","journal-title":"Curr Med Chem"},{"key":"9300_CR2","doi-asserted-by":"crossref","unstructured":"Barnes KR, Lippard SJ (2004) Metal ions in biological systems: Metal complexes in tumor diagnosis and as anticancer agents. 42:143\u2013177","DOI":"10.1201\/b12414-5"},{"key":"9300_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152007779314044","volume":"7","author":"V Cepeda","year":"2007","unstructured":"Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM (2007) Biochemical mechanisms of cisplatin cytotoxicity. Anti-Cancer Agents Med Chem 7:3\u201318","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"9300_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0010-8545(98)00268-9","volume":"185\u2013186","author":"P Yang","year":"1999","unstructured":"Yang P, Guo M (1999) Interactions of organometallic anticancer agents with nucleotides and DNA. Coord Chem Rev 185\u2013186:189\u2013211","journal-title":"Coord Chem Rev"},{"key":"9300_CR5","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1021\/cr9804238","volume":"99","author":"MJ Clarke","year":"1999","unstructured":"Clarke MJ, Zhu F, Frasca DR (1999) Non-platinum chemotherapeutic metallopharmaceuticals. Chem Rev 99:2511\u20132543","journal-title":"Chem Rev"},{"key":"9300_CR6","first-page":"1529","volume":"24","author":"B Desoize","year":"2004","unstructured":"Desoize B (2004) Metals and metal compounds in cancer treatment. Anticancer Res 24:1529\u20131544","journal-title":"Anticancer Res"},{"key":"9300_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cbpa.2007.11.013","volume":"12","author":"PCA Bruijnincx","year":"2008","unstructured":"Bruijnincx PCA, Sadler PJ (2008) New trends for metal complexes with anticancer activity. Curr Opin Chem Biol 12:197\u2013206","journal-title":"Curr Opin Chem Biol"},{"key":"9300_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1040-8428(01)00221-9","volume":"42","author":"AM Evangelou","year":"2002","unstructured":"Evangelou AM (2002) Vanadium in cancer treatment. Crit Rev Oncol Hemat 42:249\u2013265","journal-title":"Crit Rev Oncol Hemat"},{"key":"9300_CR9","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.2174\/1381612033454180","volume":"9","author":"M Galanski","year":"2003","unstructured":"Galanski M, Arion VB, Jakupec MA, Keppler BK (2003) Recent developments in the field of tumor-inhibiting metal complexes. Curr Pharm Des 9:2078\u20132089","journal-title":"Curr Pharm Des"},{"key":"9300_CR10","doi-asserted-by":"crossref","unstructured":"Jakupec MA, Galanski M, Arion VB, Hartinger CG, Keppler BK (2008) Antitumour metal compounds: more than theme and variations. Dalton Trans 183\u2013194","DOI":"10.1039\/B712656P"},{"key":"9300_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1040-8428(01)00222-0","volume":"42","author":"N Katsaros","year":"2002","unstructured":"Katsaros N, Anagnostopoulou A (2002) Rhodium and its compounds as potential agents in cancer treatment. Crit Rev Oncol Hemat 42:297\u2013308","journal-title":"Crit Rev Oncol Hemat"},{"key":"9300_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00193472","volume":"47","author":"P K\u00f6pf-Maier","year":"1994","unstructured":"K\u00f6pf-Maier P (1994) Complexes of metals other than platinum as antitumour agents. Eur J Clin Pharmacol 47:1\u201316","journal-title":"Eur J Clin Pharmacol"},{"key":"9300_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1021\/cr00081a012","volume":"87","author":"P K\u00f6pf-Maier","year":"1987","unstructured":"K\u00f6pf-Maier P, K\u00f6pf H (1987) Non-platinum group metal antitumor agents. History, current status, and perspectives. Chem Rev 87:1137\u20131152","journal-title":"Chem Rev"},{"key":"9300_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2174\/092986706776360941","volume":"13","author":"I Kostova","year":"2006","unstructured":"Kostova I (2006) Ruthenium complexes as anticancer agents. Curr Med Chem 13:1085\u20131107","journal-title":"Curr Med Chem"},{"key":"9300_CR15","first-page":"60","volume":"11","author":"F Kratz","year":"1998","unstructured":"Kratz F, Schutte MT (1998) Anticancer metal complexes and tumour targeting strategies, a review. Cancer J 11:60\u201367","journal-title":"Cancer J"},{"key":"9300_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ardp.200600151","volume":"340","author":"I Ott","year":"2007","unstructured":"Ott I, Gust R (2007) Non platinum metal complexes as anti-cancer drugs. Arch Pharm Chem Life Sci 340:117\u2013126","journal-title":"Arch Pharm Chem Life Sci"},{"key":"9300_CR17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1517\/13543776.11.6.969","volume":"11","author":"F Caruso","year":"2001","unstructured":"Caruso F, Rossi M, Pettinari C (2001) Anticancer titanium agents. Expert Opin Ther Patents 11:969\u2013979","journal-title":"Expert Opin Ther Patents"},{"key":"9300_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1040-8428(01)00224-4","volume":"42","author":"E Mel\u2019ndez","year":"2002","unstructured":"Mel\u2019ndez E (2002) Titanium complexes in cancer treatment. Crit Rev Oncol Hemat 42:309\u2013315","journal-title":"Crit Rev Oncol Hemat"},{"key":"9300_CR19","doi-asserted-by":"crossref","unstructured":"Abeysinghe PM, Harding MM (2007) Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives. Dalton Trans 3474\u20133482","DOI":"10.1039\/b707440a"},{"key":"9300_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/3-540-54261-2_2","volume":"78","author":"BK Keppler","year":"1991","unstructured":"Keppler BK, Friesen C, Moritz HG, Vongerichten H, Vogel E (1991) Struct Bond (Berlin) 78:97\u2013127","journal-title":"Struct Bond (Berlin)"},{"key":"9300_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1389557043487565","volume":"4","author":"F Caruso","year":"2004","unstructured":"Caruso F, Rossi M (2004) Antitumor titanium compounds. Mini-Rev Med Chem 4:49\u201360","journal-title":"Mini-Rev Med Chem"},{"key":"9300_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1155\/BCA.2005.317","volume":"3","author":"F Caruso","year":"2005","unstructured":"Caruso F, Rossi M, Opazo C, Pettinari C (2005) Structural features of antitumor titanium agents and related compounds. Bioinorg Chem Appl 3:317\u2013329","journal-title":"Bioinorg Chem Appl"},{"key":"9300_CR23","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1021\/jm990539b","volume":"43","author":"F Caruso","year":"2000","unstructured":"Caruso F, Rossi M, Tanski J, Sartori R, Sariego R, Moya S, Diez S, Navarrete E, Cingolani A, Marchetti F, Pettinari C (2000) Synthesis, structure, and antitumor activity of a novel tetranuclear titanium complex. J Med Chem 43:3665\u20133670","journal-title":"J Med Chem"},{"key":"9300_CR24","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1021\/ic0606375","volume":"45","author":"AM Christoforou","year":"2006","unstructured":"Christoforou AM, Marzilli PA, Marzilli LG (2006) The neglected Pt-N(sulfonamido) bond in Pt chemistry. New fluorophore-containing Pt(II) complexes useful for assessing Pt(II) interactions with biomolecules. Inorg Chem 45:6771\u20136781","journal-title":"Inorg Chem"},{"key":"9300_CR25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/00001813-200511000-00008","volume":"16","author":"G Kelter","year":"2005","unstructured":"Kelter G, Sweeney NJ, Strohfeldt K, Fiebig H-H, Tacke M (2005) In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes. Anticancer Drugs 16:1091\u20131098","journal-title":"Anticancer Drugs"},{"key":"9300_CR26","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1039\/b707310k","volume":"37","author":"K Strohfeldt","year":"2008","unstructured":"Strohfeldt K, Tacke M (2008) Bioorganometallic fulvene-derived titanocene anti-cancer drugs. Chem Soc Rev 37:1174\u20131187","journal-title":"Chem Soc Rev"},{"key":"9300_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000027075","volume":"23","author":"N Kruger","year":"2000","unstructured":"Kruger N, Kleeberg UR, Mross K, Edler L, Hossfeld DK (2000) Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer. Onkologie 23:60\u201362","journal-title":"Onkologie"},{"key":"9300_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0883-2927(00)00067-6","volume":"16","author":"M Hoch","year":"2001","unstructured":"Hoch M (2001) Organotin compounds in the environment- an overview. Appl Geochem 16:719\u2013743","journal-title":"Appl Geochem"},{"key":"9300_CR29","volume-title":"Macromolecules containing metal and metal-like elements, vol 4. Group IVB polymers","author":"C Carraher","year":"2005","unstructured":"Carraher C (2005) Macromolecules containing metal and metal-like elements, vol 4. Group IVB polymers. Wiley, Hoboken"},{"key":"9300_CR30","volume-title":"Macromolecules containing metal and metal-like elements, vol 3. Biomedical applications","author":"C Carraher","year":"2004","unstructured":"Carraher C, Siegmann-Louda D (2004) Macromolecules containing metal and metal-like elements, vol 3. Biomedical applications. Wiley, Hoboken"},{"key":"9300_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00436-003-0861-2","volume":"91","author":"MN Shuaibu","year":"2003","unstructured":"Shuaibu MN, Kanbara H, Yanagi T, Ichinose A, Ameh DA, Bonire JJ, Nok AJ (2003) In vitro trypanocidal activity of dibutyltin dichloride and its fatty acid derivatives. Jpn Parasitolog Res 91:5\u201311","journal-title":"Jpn Parasitolog Res"},{"key":"9300_CR32","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0024-3205(01)01500-4","volume":"70","author":"C-R Jan","year":"2002","unstructured":"Jan C-R, Jiann B-P, Lu Y-C, Chang H-T, Su W, Chen W-C, Yu C-C, Huang J-K (2002) Effect of the organotin compound triethyltin on Ca2+ handling in human prostate cancer cells. Life Sci 70:1337\u20131345","journal-title":"Life Sci"},{"key":"9300_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0960-894X(01)00684-9","volume":"12","author":"MP Samuel","year":"2002","unstructured":"Samuel MP, de Vos D, Raveendra D, Sarma JARP, Roy S (2002) 3-D QSAR studies on new dibenzyltin(IV) anticancer agents by comparative molecular field analysis (CoMFA). Bioorg Med Chem Lett 12:61\u201364","journal-title":"Bioorg Med Chem Lett"},{"key":"9300_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10904-007-9159-7","volume":"17","author":"CE Carraher Jr","year":"2007","unstructured":"Carraher CE Jr, Battin A, Shahi KR, Roner MR (2007) Synthesis, structural characterization, and initial evaluation as anticancer drugs of dibutyltin polyamines derived from various 4, 6-diaminopyrimidines. J Inorg Organomet Polym 17:631\u2013639","journal-title":"J Inorg Organomet Polym"},{"key":"9300_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10904-007-9158-8","volume":"17","author":"G Barot","year":"2007","unstructured":"Barot G, Shahi KR, Roner MR, Carraher CE Jr (2007) Synthesis, structural characterization, and ability to Inhibit cancer growth of a series of organotin poly(ethylene glycols). J Inorg Organomet Polym 17:595\u2013603","journal-title":"J Inorg Organomet Polym"},{"key":"9300_CR36","first-page":"525","volume":"95","author":"M Roner","year":"2006","unstructured":"Roner M, Carraher C, Sabir T, Shahi K, Roehr J, Bassett K (2006) Anticancer and antiviral activities of organotin polyether amines derived from the antiviral acyclovir. Polym Mater Sci Eng 95:525\u2013527","journal-title":"Polym Mater Sci Eng"},{"key":"9300_CR37","first-page":"556","volume":"95","author":"C Carraher","year":"2006","unstructured":"Carraher C, Ashida Y, Battin G (2006) Synthesis of organotin polyethers containing diethylstilbestrol. Polym Mater Sci Eng 95:556\u2013558","journal-title":"Polym Mater Sci Eng"},{"key":"9300_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10904-006-9050-y","volume":"16","author":"C Carraher","year":"2006","unstructured":"Carraher C, Sabir T, Roner M, Shahi K, Bleicher R, Roehr J, Bassett K (2006) Synthesis of organotin polyamine ethers containing acyclovir and their preliminary anticancer and antiviral activity. J Inorg Organomet Polym 16:249\u2013257","journal-title":"J Inorg Organomet Polym"},{"key":"9300_CR39","first-page":"153","volume":"23","author":"M Roner","year":"2006","unstructured":"Roner M, Carraher C, Roehr J, Bassett K (2006) Antiviral and anticancer activity of organotin polymers and reactants derived from norfloxacin and ampicillin. J Polym Mater 23:153\u2013159","journal-title":"J Polym Mater"},{"key":"9300_CR40","first-page":"564","volume":"91","author":"R Doucette","year":"2004","unstructured":"Doucette R, Siegmann-Louda D, Carraher C, Cardoso A (2004) Inhibition of Balb 3T3 cells as a function of metal for kinetin containing polymers. Polym Mater Sci Eng 91:564\u2013566","journal-title":"Polym Mater Sci Eng"},{"key":"9300_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1039\/b312109g","volume":"100","author":"PJ Blower","year":"2004","unstructured":"Blower PJ (2004) Inorganic pharmaceuticals. Annu Rep Prog Chem Sect A 100:633\u2013658","journal-title":"Annu Rep Prog Chem Sect A"},{"key":"9300_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0010-8545(01)00399-X","volume":"224","author":"L Pellerito","year":"2002","unstructured":"Pellerito L, Nagy L (2002) Organotin(IV)n+ complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects. Coord Chem Rev 224:111\u2013150","journal-title":"Coord Chem Rev"},{"key":"9300_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0020-1693(00)88160-8","volume":"93","author":"AJ Crowe","year":"1984","unstructured":"Crowe AJ, Smith PJ, Atassi G (1984) Investigations into the antitumor activity of organotin compounds. 2. Diorganotin dihalide and dipseudohalide complexes. Inorg Chim Acta 93:179\u2013184","journal-title":"Inorg Chim Acta"},{"key":"9300_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/(SICI)1099-0739(199807)12:7<503::AID-AOC746>3.0.CO;2-P","volume":"12","author":"S Basu Baul","year":"1998","unstructured":"Basu Baul S, Basu Baul TS, Rivarola E, Dakternieks D, Tiekink ERT, Syng-ai C, Chatterjee A (1998) Synthesis and characterization of diorganotin(IV) complexes of N-(2-Pyridylmethylene)arylamines and Mutagenecity testing of Et2SnCl2.L4 [L4 = N-(2-Pyridylmethylene)-4-toluidine. Appl Organomet Chem 12:503\u2013513","journal-title":"Appl Organomet Chem"},{"key":"9300_CR45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/jat.1290","volume":"28","author":"B Koch","year":"2008","unstructured":"Koch B, BasuBaul TS, Chatterjee A (2008) Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds. J Appl Toxicol 28:430\u2013438","journal-title":"J Appl Toxicol"},{"key":"9300_CR46","first-page":"207","volume":"214","author":"S Basu Baul","year":"1999","unstructured":"Basu Baul S, Basu Baul TS, Tiekink ERT (1999) Crystal structure of dichlorodimethyl [N-(2-Pyridylmethylene)-3-toluidine]tin, C15H18Cl2N2Sn, Z. Kristallogr. (NCS) 214:207\u2013208.","journal-title":"Z. Kristallogr. (NCS)"},{"key":"9300_CR47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1383-5718(01)00289-3","volume":"513","author":"C Syng-ai","year":"2002","unstructured":"Syng-ai C, Basu Baul T, Chatterjee A (2002) Antiproliferative and cytotoxic effect of a novel organotin compound on mammalian cells both in vitro and in vivo. Mutat Res 513:49\u201359","journal-title":"Mutat Res"},{"key":"9300_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10637-008-9176-6","volume":"27","author":"B Koch","year":"2008","unstructured":"Koch B, BasuBaul TS, Chatterjee A (2008) p53-dependent antiproliferative and antitumor effect of novel alkyl series of diorganotin(IV) compounds. Invest New Drugs 27:319\u2013326","journal-title":"Invest New Drugs"},{"key":"9300_CR49","first-page":"1","volume":"3","author":"MR Boyd","year":"1989","unstructured":"Boyd MR (1989) Status of the NCI preclinical antitumor drug discovery screen. Principles and practice of oncology 3:1\u201312","journal-title":"Principles and practice of oncology"},{"key":"9300_CR50","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0277-5379(91)90142-Z","volume":"27","author":"YP Keepers","year":"1991","unstructured":"Keepers YP, Pizao PR, Peters GJ, Ark-Otte JV, Winograd B, Pinedo HM (1991) Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer 27:897\u2013900","journal-title":"Eur J Cancer"},{"key":"9300_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3835(84)90078-8","volume":"24","author":"AJ Crowe","year":"1984","unstructured":"Crowe AJ, Smith PJ, Cardin CJ, Parge HE, Smith FE (1984) Possible predissociation of diorganotin dihalide complexes-relationship between antitumor activity and structure. Cancer Lett 24:45\u201358","journal-title":"Cancer Lett"},{"key":"9300_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0020-1693(00)82967-9","volume":"196","author":"M Gielen","year":"1992","unstructured":"Gielen M, Lelieveld P, de Vos D, Pan H, Willem R, Biesemans M, Fiebig HH (1992) In vitro effect of organotin-substituted steroids in human tumor cell lines. Inorg Chim Acta 196:115\u2013117","journal-title":"Inorg Chim Acta"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-009-9300-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9300-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:41:50Z","timestamp":1678509710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-009-9300-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,27]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["9300"],"URL":"https:\/\/doi.org\/10.1007\/s10637-009-9300-2","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,27]]},"assertion":[{"value":"16 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}